Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

Literature DB >> 19500485

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

James K Liao¹.

Abstract

Entities: Chemical Gene Species

Year: 2009 PMID： 19500485 DOI： 10.1007/s11883-009-0037-3

Source DB: PubMed Journal: Curr Atheroscler Rep ISSN： 1523-3804 Impact factor: 5.113

× No keyword cloud information.

9 in total

1. C-reactive protein and coronary heart disease.

Authors: Paul M Ridker; Wolfgang Koenig; Valentin Fuster
Journal: N Engl J Med Date: 2004-07-15 Impact factor: 91.245

2. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.

Authors: P M Ridker; N Rifai; M Clearfield; J R Downs; S E Weis; J S Miles; A M Gotto
Journal: N Engl J Med Date: 2001-06-28 Impact factor: 91.245

3. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.

Authors: P M Ridker; C H Hennekens; J E Buring; N Rifai
Journal: N Engl J Med Date: 2000-03-23 Impact factor: 91.245

4. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.

Authors: Paul M Ridker; Nader Rifai; Lynda Rose; Julie E Buring; Nancy R Cook
Journal: N Engl J Med Date: 2002-11-14 Impact factor: 91.245

5. C-reactive protein levels and outcomes after statin therapy.

Authors: Paul M Ridker; Christopher P Cannon; David Morrow; Nader Rifai; Lynda M Rose; Carolyn H McCabe; Marc A Pfeffer; Eugene Braunwald
Journal: N Engl J Med Date: 2005-01-06 Impact factor: 91.245

6. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.

Authors: P M Ridker; M Cushman; M J Stampfer; R P Tracy; C H Hennekens
Journal: N Engl J Med Date: 1997-04-03 Impact factor: 91.245

Review 7. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Authors: Scott M Grundy; James I Cleeman; C Noel Bairey Merz; H Bryan Brewer; Luther T Clark; Donald B Hunninghake; Richard C Pasternak; Sidney C Smith; Neil J Stone
Journal: Circulation Date: 2004-07-13 Impact factor: 29.690

8. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

Authors: J R Downs; M Clearfield; S Weis; E Whitney; D R Shapiro; P A Beere; A Langendorfer; E A Stein; W Kruyer; A M Gotto
Journal: JAMA Date: 1998-05-27 Impact factor: 56.272

9. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Authors:
Journal: Lancet Date: 2002-07-06 Impact factor: 79.321

9 in total

7 in total

1. ETC-1002 regulates immune response, leukocyte homing, and adipose tissue inflammation via LKB1-dependent activation of macrophage AMPK.

Authors: Sergey Filippov; Stephen L Pinkosky; Richard J Lister; Catherine Pawloski; Jeffrey C Hanselman; Clay T Cramer; Rai Ajit K Srivastava; Timothy R Hurley; Cheryl D Bradshaw; Mark A Spahr; Roger S Newton
Journal: J Lipid Res Date: 2013-05-24 Impact factor: 5.922

2. Clinical Characteristics and Angiographic Findings of Acute Myocardial Infarction Associated With Marijuana Use: Consecutive Case Series.

Authors: Navneet Sharma; Justin Lee; Carla Saladini Aponte; Jonathan D Marmur; William E Lawson; Noelle N Mann; Moro O Salifu; Irini Youssef; Samy I McFarlane
Journal: Scifed J Cardiol Date: 2017-11-22

Review 3. The Clinical Significance and Potential Role of C-Reactive Protein in Chronic Inflammatory and Neurodegenerative Diseases.

Authors: Ying-Yi Luan; Yong-Ming Yao
Journal: Front Immunol Date: 2018-06-07 Impact factor: 7.561

4. Are interventions to improve cardiovascular disease risk factors in premenopausal women effective? A systematic review and meta-analysis.

Authors: Lan Gao; Jan Faller; Ishani Majmudar; Phuong Nguyen; Marj Moodie
Journal: BMJ Open Date: 2021-07-28 Impact factor: 2.692